Saturday October 15 |
| 8:00 | Chairman's Welcome and Introduction |
|---|
| | Laurence Klotz, MD, Canada |
| | |
| 8:15 | SESSION ONE | Prostate Cancer Prevention |
|---|
| | Moderator: Hideyuki Akaza, MD, Japan |
| | |
| 8:20 | 5ARIs and Prostate Cancer Prevention Following the FDA Decision |
|---|
| | Neil Fleshner, MD, Canada |
| | |
| 8:35 | Diet, Statins, Cholesterol |
|---|
| | Hanjong Ahn, MD, South Korea |
| | |
| 8:50 | Curcumin and Other Micronutrients |
|---|
| | Shigeo Horie, MD, Japan |
| | |
| 9:05 | DISCUSSION |
|---|
| | |
| 9:20 | Exercise in Prostate Cancer |
|---|
| | Arturo Mendoza Valdes, MD, Mexico |
| | |
| 9:35 | Pre-clinical Models of Prostate Cancer Prevention |
|---|
| | Hirotsugu Uemura, MD, Japan |
| | |
| 9:50 | DISCUSSION |
|---|
| | |
| 10:00 | BREAK |
|---|
| | |
| 10:15 | SESSION TWO | Town Hall Forum |
|---|
| | Moderator: Laurence Klotz, MD, Canada |
| | |
| 10:20 | Screening in Men Over Age 65 | Introduction |
|---|
| | Laurence Klotz, MD, Canada |
| | |
| 10:25 | Overdiagnosis and How to Avoid This |
|---|
| | Monique Roobol, PhD, The Netherlands |
| | |
| 10:35 | An Epidemiologic Perspective |
|---|
| | Peter Albertsen, MD, USA |
| | |
| 10:45 | Pros and Cons of Screening Over Age 65 |
|---|
| | Franz Recker, MD, Switzerland |
| | |
| 11:05 | GROUP DISCUSSION: Healthy Men - The Case for Continuing to Screen Over Age 65 |
|---|
| | Albertsen, Roobol, Recker, Evans |
| | |
| 11:25 | SESSION THREE |
|---|
| | Update on Biomarkers |
| | Moderator: Peter Albers, MD, Germany |
| | |
| 11:30 | PCA3 |
|---|
| | Inge Van Oort, MD, The Netherlands |
| | |
| 11:40 | Seminal Fluid Markers |
|---|
| | Frank Gardiner, MD, Australia |
| | |
| 11:50 | Serum Biomarkers |
|---|
| | John Davis, MD, USA |
| | |
| 12:00 | DISCUSSION |
|---|
| | |
| 12:15 | Angiogenesis and Lymphangiogenesis in Prostate Cancer |
|---|
| | Derya Tilki, MD, Germany |
| | |
| 12:25 | MRI as a Prostate Cancer Detection Tool. Where are We Right Now? |
|---|
| | Mark Emberton, MD, UK |
| | |
| 12:35 | DISCUSSION |
|---|
| | |
| 12:45 | 40 MINUTE LUNCH BREAK |
|---|
| | Lunch Available for Purchase |
| | |
| 1:30 | SESSION FOUR |
|---|
| | Mechanisms of Castrate Resistance |
| | Moderator: David Gillatt, MD, UK |
| | |
| 1:35 | Intermittent vs Continuous Androgen Deprivation Therapy and Biological Implications |
|---|
| | Laurence Klotz, MD, Canada |
| | |
| 1:50 | Autophagy and Prostate Cancer |
|---|
| | Christopher Evans, MD, USA |
| | |
| 2:05 | Immune Escape and Prostate Cancer |
|---|
| | Rob Siemens, MD, Canada |
| | |
| 2:20 | DISCUSSION |
|---|
| | |
| 2:35 | Adapting Treatment Strategies for CRPCa in the Elderly |
|---|
| | Fred Saad, MD, Canada |
| | |
| 2:50 | Focal MR-Guided Thermotherapy - An Update |
|---|
| | John Trachtenberg, MD, Canada |
| | |
| 3:05 | DISCUSSION |
|---|
| | |
| 3:20 | BREAK |
|---|
| | |
| 3:30 | SESSION FIVE | Kidney |
|---|
| | Moderator: Marcelo Bendhack, MD, Brazil |
| | |
| 3:45 | Small Renal Masses: Indications for Intervention in Elderly Patients |
|---|
| | Antonio Finelli, MD, Canada |
| | |
| 3:50 | Partial Nephrectomy in the Elderly |
|---|
| | Thomas Schwaab, MD, USA |
| | |
| 4:05 | Role of Biopsy in Management of Renal Masses |
|---|
| | Michael Jewett, MD, Canada |
| | |
| 4:20 | CASE DISCUSSION |
|---|
| | |
| 4:35 | Incorporation of TKIs into Surgical Management |
|---|
| | Anil Kapoor, MD, Canada |
| | |
| 4:50 | Lessons Learned from Partial vs Radical Nephrectomy Studies |
|---|
| | Hein van Poppel, MD, Belgium |
| | |
| 5:05 | CASE DISCUSSION |
|---|
| | |
| 5:20 | CONCLUDE |
|---|
| | |
| | |
Sunday October 16 |
| 8:00 | SESSION SIX | Bladder Cancer Biology |
|---|
| | Moderator: Michael Droller, MD, USA |
| | |
| 8:05 | Update on New Diagnostic Methods |
|---|
| | Fred Witjes, MD, The Netherlands |
| | |
| 8:20 | Tissue Markers |
|---|
| | Peter Black, MD, Canada |
| | |
| 8:35 | DISCUSSION |
|---|
| | |
| 8:45 | Management of Invasive Bladder Cancer in the Elderly |
|---|
| | Shahrokh Shariat, MD, USA |
| | |
| 9:00 | Management of Non-muscle Invasive Bladder Cancer in China |
|---|
| | Ningchen Li, MD, China |
| | |
| 9:15 | Considerations for Treatment Decisions in Bladder Cancer |
|---|
| | Michael Droller, MD, USA |
| | |
| 9:30 | DISCUSSION |
|---|
| | |
| 9:45 | BREAK |
|---|
| | |
| 10:05 | SESSION SEVEN | Surgical Management of Invasive Bladder Cancer |
|---|
| | Moderator: Urs Studer, MD, Switzerland |
| | |
| 10:10 | Role of Extended Node Dissection |
|---|
| | Wassim Kassouf, MD, Canada |
| | |
| 10:25 | Quality of Care in the Management of Bladder Cancer |
|---|
| | Badrinath Konety, MD, USA |
| | |
| 10:40 | Orthotopic Bladder in Elderly Patients: Limits and Results |
|---|
| | Richard Hautmann, MD, Germany |
| | |
| 10:55 | DISCUSSION |
|---|
| | |
| 11:10 | SESSION EIGHT |
|---|
| | Moderator: Christopher Cheng, MD, Singapore |
| | |
| 11:15 | Why and How to do a Nerve Sparing Cystectomy |
|---|
| | Urs Studer, MD, Switzerland |
| | |
| 11:30 | Upper Tract TCC - Role of Neoadjuvant Therapy |
|---|
| | Surena Matin, MD, USA |
| | |
| 11:45 | Neo Adjuvant vs Adjuvant Chemotherapy - Which is Preferable? |
|---|
| | Peter Albers, MD, Germany |
| | |
| 12:00 | DISCUSSION |
|---|
| | |
| 12:15 | WRAP UP |
|---|
| | Laurence Klotz, MD, Canada |
| | |
| 12:20 | ADJOURN |
|---|
